APA

Cascinu S., Rosati G., Nasti G., Lonardi S., Zaniboni A., Marchetti P., Leone F., Bilancia D., Iaffaioli R. V., Zagonel V., Giordano M., Corsi D. C., Ferraú F., Labianca R., Ronzoni M., Scartozzi M. & Galli F. (20170911). Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients. : European journal of cancer (Oxford, England : 1990).

Chicago

Cascinu Stefano, Rosati Gerardo, Nasti Guglielmo, Lonardi Sara, Zaniboni Alberto, Marchetti Paolo, Leone Francesco, Bilancia Domenico, Iaffaioli Rosario Vincenzo, Zagonel Vittorina, Giordano Monica, Corsi Domenico C, Ferraú Francesco, Labianca Roberto, Ronzoni Monica, Scartozzi Mario and Galli Francesca. 20170911. Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients. : European journal of cancer (Oxford, England : 1990).

Harvard

Cascinu S., Rosati G., Nasti G., Lonardi S., Zaniboni A., Marchetti P., Leone F., Bilancia D., Iaffaioli R. V., Zagonel V., Giordano M., Corsi D. C., Ferraú F., Labianca R., Ronzoni M., Scartozzi M. and Galli F. (20170911). Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients. : European journal of cancer (Oxford, England : 1990).

MLA

Cascinu Stefano, Rosati Gerardo, Nasti Guglielmo, Lonardi Sara, Zaniboni Alberto, Marchetti Paolo, Leone Francesco, Bilancia Domenico, Iaffaioli Rosario Vincenzo, Zagonel Vittorina, Giordano Monica, Corsi Domenico C, Ferraú Francesco, Labianca Roberto, Ronzoni Monica, Scartozzi Mario and Galli Francesca. Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients. : European journal of cancer (Oxford, England : 1990). 20170911.